Skip to main navigation Skip to search Skip to main content

Diagnosis, treatment and prevention of infective endocarditis: Turkish consensus report-2019

  • Serap Şimşek Yavuz
  • , Ahmet Rüçhan Akar
  • , Sinan Aydoğdu
  • , Denef Berzeg Deniz
  • , Hakan Demir
  • , Tuncay Hazırolan
  • , Mehmet Ali Özatik
  • , Necla Özer
  • , Murat Sargın
  • , Emine Nursen Topcuoğlu
  • , Nesrin Turhan
  • , Mehmet Birhan Yılmaz
  • , Özlem Azap
  • , Seniha Başaran
  • , Yasemin Çağ
  • , Atahan Çağatay
  • , Güle Çınar
  • , Sibel Doğan Kaya
  • , Lokman Hızmalı
  • , Mehmet Emirhan Işık
  • Nirgül Kılıçaslan, Şirin Menekşe, Meliha Meriç-Koç, Serpil Öztürk, Ayfer Şensoy, Yasemin Tezer-Tekçe, Elif Tükenmez-Tigen, Yeşim Uygun-Kızmaz, Mutlu Şeyda Velioğlu-Öcalmaz, Ayşegül Yeşilkaya, Emel Yılmaz, Neziha Yılmaz, Fatma Yılmaz-Karadağ
  • Istanbul University
  • Ankara University
  • Hacettepe University
  • Kocaeli University
  • Ankara City Hospital

Research output: Contribution to journalReview articlepeer-review

9 Citations (Scopus)

Abstract

Infective endocarditis (IE) is a rare but still important as an infectious disease due to high rate of morbidity and substantial mortality. Although IE is not a notifiable disease in Turkey, and an incidence study has not been performed, the incidence may be higher than that in the developed countries due to frequent predisposing cardiac conditions and higher rates of nosocomial bacteremia, which may lead to IE in risk groups. IE generally affects the elderly in developed countries but it is frequently encountered among young individuals in Turkey. In order to reduce mortality and morbidity, it is critical to diagnose IE, to determine the causative agent, and to start treatment rapidly. Most patients cannot be diagnosed at the first visit, about half can be diagnosed after 3 months, and the disease often goes unnoticed. In patients diagnosed with IE, the rate of the identification of a causative organism is significantly lower in Turkey than that in developed countries. Some important microbiological diagnostic tests are not performed in most centers and several antimicrobials that are recommended as the first option for the treatment particularly antistaphylococcal penicillins, are unavailable in Turkey. These problems necessitate reviewing the epidemiological, laboratory, and clinical characteristics of IE in our country, as well as the current information about its diagnosis, treatment, and prevention together with local data. The diagnosis and treatment processes of IE should be standardized at every stage so that the management can be conducted in a setting in which physicians of various specialties are involved and is consistent with the current recommendations. The Study Group for Infective Endocarditis and Other Cardiovascular Infections of the Turkish Society of Clinical Microbiology and Infectious Diseases called for the collaboration of the relevant specialist organizations to establish a consensus report on the diagnosis, treatment, and prevention of IE in the context of current information and local data in Turkey.

Translated title of the contributionİnfektif endokarditin tanısı, tedavisi ve önlenmesi: Ulusal uzlaşı raporu-2019
Original languageEnglish
Pages (from-to)187-226
Number of pages40
JournalTurk Kardiyoloji Dernegi Arsivi
Volume48
Issue number2
DOIs
Publication statusPublished - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Consensus report
  • Infective endocarditis

Fingerprint

Dive into the research topics of 'Diagnosis, treatment and prevention of infective endocarditis: Turkish consensus report-2019'. Together they form a unique fingerprint.

Cite this